Glycyrrhizin as a nitric oxide regulator in cancer chemotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Minsu | - |
dc.contributor.author | Park, Seok Chan | - |
dc.contributor.author | Lee, Dong Yun | - |
dc.date.accessioned | 2022-07-06T11:37:08Z | - |
dc.date.available | 2022-07-06T11:37:08Z | - |
dc.date.created | 2021-12-08 | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 2072-6694 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/140442 | - |
dc.description.abstract | Chemotherapy is used widely for cancer treatment; however, the evolution of multidrug resistance (MDR) in many patients limits the therapeutic benefits of chemotherapy. It is important to overcome MDR for enhanced chemotherapy. ATP-dependent efflux of drugs out of cells is the main mechanism of MDR. Recent studies have suggested that nitric oxide (NO) can be used to overcome MDR by inhibiting the ATPase function of ATP-dependent pumps. Several attempts have been made to deliver NO to the tumor microenvironment (TME), however there are limitations in delivery. Glycyrrhizin (GL), an active compound of licorice, has been reported to both reduce the MDR effect by inhibiting ATP-dependent pumps and function as a regulator of NO production in the TME. In this review, we describe the potential role of GL as an NO regulator and MDR inhibitor that efficiently reduces the MDR effect in cancer chemotherapy. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | Glycyrrhizin as a nitric oxide regulator in cancer chemotherapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Dong Yun | - |
dc.identifier.doi | 10.3390/cancers13225762 | - |
dc.identifier.scopusid | 2-s2.0-85119121051 | - |
dc.identifier.wosid | 000726918700001 | - |
dc.identifier.bibliographicCitation | Cancers, v.13, no.22, pp.1 - 22 | - |
dc.relation.isPartOf | Cancers | - |
dc.citation.title | Cancers | - |
dc.citation.volume | 13 | - |
dc.citation.number | 22 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 22 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | MULTIDRUG-RESISTANCE PROTEIN-1 | - |
dc.subject.keywordPlus | DRUG-METABOLIZING-ENZYMES | - |
dc.subject.keywordPlus | P-GLYCOPROTEIN | - |
dc.subject.keywordPlus | CO-DELIVERY | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | GLYCYRRHETINIC ACID | - |
dc.subject.keywordPlus | SYNTHASE EXPRESSION | - |
dc.subject.keywordPlus | RNA INTERFERENCE | - |
dc.subject.keywordPlus | PACLITAXEL TAXOL | - |
dc.subject.keywordPlus | S-NITROSYLATION | - |
dc.subject.keywordAuthor | ATP-biding cassette | - |
dc.subject.keywordAuthor | Chemotherapy | - |
dc.subject.keywordAuthor | Glycyrrhizin | - |
dc.subject.keywordAuthor | Multidrug resistance | - |
dc.subject.keywordAuthor | Nitric oxide | - |
dc.subject.keywordAuthor | Tumor microenvironment | - |
dc.identifier.url | https://www.mdpi.com/2072-6694/13/22/5762 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.